Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.

Market Analysis and Insights: Global Kidney & Renal Fibrosis Treatment Market

The global Kidney & Renal Fibrosis Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Kidney & Renal Fibrosis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Kidney & Renal Fibrosis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney & Renal Fibrosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney & Renal Fibrosis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kidney & Renal Fibrosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kidney & Renal Fibrosis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Kidney & Renal Fibrosis Treatment Market Report

Report Metric	Details
Report Name	Kidney & Renal Fibrosis Treatment Market
CAGR	5%
Segment by Type	Angiotensin II Receptor Blockers (ARBs) Angiotensin Converting Enzyme (ACE) Inhibitors Pirfenidone Renin Inhibitors Vasopeptidase Inhibitors
Segment by Application	Commercial/Private Hospitals Public Health Hospitals Clinics Home Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Galectin Therapeutics, Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., InterMune Inc., ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, Genzyme Corporation, BioLine Rx Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kidney & Renal Fibrosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney & Renal Fibrosis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney & Renal Fibrosis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The main players in the Kidney & Renal Fibrosis Treatment Market are Galectin Therapeutics, Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., InterMune Inc., ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, Genzyme Corporation, BioLine Rx Ltd

What are the Application segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The Applications covered in the Kidney & Renal Fibrosis Treatment Market report are Commercial/Private Hospitals, Public Health Hospitals, Clinics, Home Treatment

What are the Type segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The Types covered in the Kidney & Renal Fibrosis Treatment Market report are Angiotensin II Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Angiotensin II Receptor Blockers (ARBs)

1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors

1.2.4 Pirfenidone

1.2.5 Renin Inhibitors

1.2.6 Vasopeptidase Inhibitors

1.3 Market by Application

1.3.1 Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Commercial/Private Hospitals

1.3.3 Public Health Hospitals

1.3.4 Clinics

1.3.5 Home Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney & Renal Fibrosis Treatment Market Perspective (2019-2030)

2.2 Global Kidney & Renal Fibrosis Treatment Growth Trends by Region

2.2.1 Kidney & Renal Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney & Renal Fibrosis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Kidney & Renal Fibrosis Treatment Market Dynamics

2.3.1 Kidney & Renal Fibrosis Treatment Industry Trends

2.3.2 Kidney & Renal Fibrosis Treatment Market Drivers

2.3.3 Kidney & Renal Fibrosis Treatment Market Challenges

2.3.4 Kidney & Renal Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Kidney & Renal Fibrosis Treatment by Players

3.1.1 Global Kidney & Renal Fibrosis Treatment Revenue by Players (2019-2024)

3.1.2 Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Kidney & Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Kidney & Renal Fibrosis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio

3.4.1 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney & Renal Fibrosis Treatment Revenue in 2023

3.5 Global Key Players of Kidney & Renal Fibrosis Treatment Head office and Area Served

3.6 Global Key Players of Kidney & Renal Fibrosis Treatment, Product and Application

3.7 Global Key Players of Kidney & Renal Fibrosis Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney & Renal Fibrosis Treatment Breakdown Data by Type

4.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2025-2030)

5 Kidney & Renal Fibrosis Treatment Breakdown Data by Application

5.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

6.2 North America Kidney & Renal Fibrosis Treatment Market Size by Type

6.2.1 North America Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024)

6.2.2 North America Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030)

6.2.3 North America Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

6.3 North America Kidney & Renal Fibrosis Treatment Market Size by Application

6.3.1 North America Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024)

6.3.2 North America Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030)

6.3.3 North America Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

6.4 North America Kidney & Renal Fibrosis Treatment Market Size by Country

6.4.1 North America Kidney & Renal Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

6.4.3 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

7.2 Europe Kidney & Renal Fibrosis Treatment Market Size by Type

7.2.1 Europe Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024)

7.2.2 Europe Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030)

7.2.3 Europe Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

7.3 Europe Kidney & Renal Fibrosis Treatment Market Size by Application

7.3.1 Europe Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024)

7.3.2 Europe Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030)

7.3.3 Europe Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

7.4 Europe Kidney & Renal Fibrosis Treatment Market Size by Country

7.4.1 Europe Kidney & Renal Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

7.4.3 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

8.2 China Kidney & Renal Fibrosis Treatment Market Size by Type

8.2.1 China Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024)

8.2.2 China Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030)

8.2.3 China Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

8.3 China Kidney & Renal Fibrosis Treatment Market Size by Application

8.3.1 China Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024)

8.3.2 China Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030)

8.3.3 China Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

9.2 Asia Kidney & Renal Fibrosis Treatment Market Size by Type

9.2.1 Asia Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024)

9.2.2 Asia Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030)

9.2.3 Asia Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

9.3 Asia Kidney & Renal Fibrosis Treatment Market Size by Application

9.3.1 Asia Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024)

9.3.2 Asia Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030)

9.3.3 Asia Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

9.4 Asia Kidney & Renal Fibrosis Treatment Market Size by Region

9.4.1 Asia Kidney & Renal Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024)

9.4.3 Asia Kidney & Renal Fibrosis Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Galectin Therapeutics

11.1.1 Galectin Therapeutics Company Details

11.1.2 Galectin Therapeutics Business Overview

11.1.3 Galectin Therapeutics Kidney & Renal Fibrosis Treatment Introduction

11.1.4 Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.1.5 Galectin Therapeutics Recent Developments

11.2 Merck & Co.

11.2.1 Merck & Co. Company Details

11.2.2 Merck & Co. Business Overview

11.2.3 Merck & Co. Kidney & Renal Fibrosis Treatment Introduction

11.2.4 Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.2.5 Merck & Co. Recent Developments

11.3 F. Hoffman-La Roche Ltd.

11.3.1 F. Hoffman-La Roche Ltd. Company Details

11.3.2 F. Hoffman-La Roche Ltd. Business Overview

11.3.3 F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Introduction

11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.3.5 F. Hoffman-La Roche Ltd. Recent Developments

11.4 Pfizer Inc.

11.4.1 Pfizer Inc. Company Details

11.4.2 Pfizer Inc. Business Overview

11.4.3 Pfizer Inc. Kidney & Renal Fibrosis Treatment Introduction

11.4.4 Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.4.5 Pfizer Inc. Recent Developments

11.5 InterMune Inc.

11.5.1 InterMune Inc. Company Details

11.5.2 InterMune Inc. Business Overview

11.5.3 InterMune Inc. Kidney & Renal Fibrosis Treatment Introduction

11.5.4 InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.5.5 InterMune Inc. Recent Developments

11.6 ProMetic Life-Sciences Inc.

11.6.1 ProMetic Life-Sciences Inc. Company Details

11.6.2 ProMetic Life-Sciences Inc. Business Overview

11.6.3 ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Introduction

11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.6.5 ProMetic Life-Sciences Inc. Recent Developments

11.7 La Jolla Pharmaceutical Company

11.7.1 La Jolla Pharmaceutical Company Company Details

11.7.2 La Jolla Pharmaceutical Company Business Overview

11.7.3 La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Introduction

11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.7.5 La Jolla Pharmaceutical Company Recent Developments

11.8 Genzyme Corporation

11.8.1 Genzyme Corporation Company Details

11.8.2 Genzyme Corporation Business Overview

11.8.3 Genzyme Corporation Kidney & Renal Fibrosis Treatment Introduction

11.8.4 Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.8.5 Genzyme Corporation Recent Developments

11.9 BioLine Rx Ltd

11.9.1 BioLine Rx Ltd Company Details

11.9.2 BioLine Rx Ltd Business Overview

11.9.3 BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Introduction

11.9.4 BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.9.5 BioLine Rx Ltd Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Galectin Therapeutics

Merck

F. Hoffman-La Roche Ltd.

Pfizer Inc

InterMune

ProMetic Life Sciences Inc

La Jolla Pharmaceutical Company

Genzyme Corporation

BioLine Rx Ltd

List of Tables

Table 1. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs)

Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors

Table 4. Key Players of Pirfenidone

Table 5. Key Players of Renin Inhibitors

Table 6. Key Players of Vasopeptidase Inhibitors

Table 7. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2019-2024)

Table 11. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2025-2030)

Table 13. Kidney & Renal Fibrosis Treatment Market Trends

Table 14. Kidney & Renal Fibrosis Treatment Market Drivers

Table 15. Kidney & Renal Fibrosis Treatment Market Challenges

Table 16. Kidney & Renal Fibrosis Treatment Market Restraints

Table 17. Global Kidney & Renal Fibrosis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Kidney & Renal Fibrosis Treatment Revenue Share by Players (2019-2024)

Table 19. Global Top Kidney & Renal Fibrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2023)

Table 20. Global Kidney & Renal Fibrosis Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Kidney & Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Kidney & Renal Fibrosis Treatment, Headquarters and Area Served

Table 23. Global Key Players of Kidney & Renal Fibrosis Treatment, Product and Application

Table 24. Global Key Players of Kidney & Renal Fibrosis Treatment, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Kidney & Renal Fibrosis Treatment Revenue Share by Application (2019-2024)

Table 32. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Kidney & Renal Fibrosis Treatment Revenue Share by Application (2025-2030)

Table 34. North America Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Kidney & Renal Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Kidney & Renal Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Kidney & Renal Fibrosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Kidney & Renal Fibrosis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 66. Galectin Therapeutics Company Details

Table 67. Galectin Therapeutics Business Overview

Table 68. Galectin Therapeutics Kidney & Renal Fibrosis Treatment Product

Table 69. Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 70. Galectin Therapeutics Recent Developments

Table 71. Merck & Co. Company Details

Table 72. Merck & Co. Business Overview

Table 73. Merck & Co. Kidney & Renal Fibrosis Treatment Product

Table 74. Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 75. Merck & Co. Recent Developments

Table 76. F. Hoffman-La Roche Ltd. Company Details

Table 77. F. Hoffman-La Roche Ltd. Business Overview

Table 78. F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Product

Table 79. F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 80. F. Hoffman-La Roche Ltd. Recent Developments

Table 81. Pfizer Inc. Company Details

Table 82. Pfizer Inc. Business Overview

Table 83. Pfizer Inc. Kidney & Renal Fibrosis Treatment Product

Table 84. Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 85. Pfizer Inc. Recent Developments

Table 86. InterMune Inc. Company Details

Table 87. InterMune Inc. Business Overview

Table 88. InterMune Inc. Kidney & Renal Fibrosis Treatment Product

Table 89. InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 90. InterMune Inc. Recent Developments

Table 91. ProMetic Life-Sciences Inc. Company Details

Table 92. ProMetic Life-Sciences Inc. Business Overview

Table 93. ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Product

Table 94. ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 95. ProMetic Life-Sciences Inc. Recent Developments

Table 96. La Jolla Pharmaceutical Company Company Details

Table 97. La Jolla Pharmaceutical Company Business Overview

Table 98. La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Product

Table 99. La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 100. La Jolla Pharmaceutical Company Recent Developments

Table 101. Genzyme Corporation Company Details

Table 102. Genzyme Corporation Business Overview

Table 103. Genzyme Corporation Kidney & Renal Fibrosis Treatment Product

Table 104. Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 105. Genzyme Corporation Recent Developments

Table 106. BioLine Rx Ltd Company Details

Table 107. BioLine Rx Ltd Business Overview

Table 108. BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Product

Table 109. BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 110. BioLine Rx Ltd Recent Developments

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Kidney & Renal Fibrosis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Angiotensin II Receptor Blockers (ARBs) Features

Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features

Figure 5. Pirfenidone Features

Figure 6. Renin Inhibitors Features

Figure 7. Vasopeptidase Inhibitors Features

Figure 8. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Kidney & Renal Fibrosis Treatment Market Share by Application: 2023 VS 2030

Figure 10. Commercial/Private Hospitals Case Studies

Figure 11. Public Health Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Home Treatment Case Studies

Figure 14. Kidney & Renal Fibrosis Treatment Report Years Considered

Figure 15. Global Kidney & Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Kidney & Renal Fibrosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Kidney & Renal Fibrosis Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players in 2023

Figure 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Kidney & Renal Fibrosis Treatment Revenue in 2023

Figure 21. North America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

Figure 23. North America Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

Figure 24. North America Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 25. United States Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Kidney & Renal Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

Figure 29. Europe Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

Figure 30. Europe Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 31. Germany Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Kidney & Renal Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

Figure 39. China Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

Figure 40. Asia Kidney & Renal Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

Figure 42. Asia Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

Figure 43. Asia Kidney & Renal Fibrosis Treatment Market Share by Region (2019-2030)

Figure 44. Japan Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 54. Brazil Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Galectin Therapeutics Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 61. Merck & Co. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 62. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 63. Pfizer Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 64. InterMune Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 65. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 66. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 67. Genzyme Corporation Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 68. BioLine Rx Ltd Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Therapeutic Market Research Report 2025

Global Chronic Kidney Disease Treatment Market Research Report 2025

Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease CKD Treatment Market Research Report 2025

Global Kidney Medicine Market Insights Forecast to 2030

Global Treatment of Skin Fibrosis Market Insights Forecast to 2030

Global End Stage Renal Disease ESRD Treatment Market Research Report 2025

Global CKD and ESRD Treatment Market Research Report 2025

Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024

Global Acute Kidney Injury Treatment Market Insights Forecast to 2030

Global Renal Disease Treatment Market Research Report 2024

End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Proteinuria Treatment Market Insights Forecast to 2030

Global Renal Diseases Drug Market Insights Forecast to 2030

Global End Stage Kidney Disease Market Research Report 2024

End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Drug Therapy Market Insights Forecast to 2030

Global Cystic Fibrosis Treatment Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-30Y11880

Mon Mar 24 00:00:00 UTC 2025

Add to Cart

Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-37C12056

Mon Mar 24 00:00:00 UTC 2025

Add to Cart

Global Anesthesia Video Laryngoscope Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-21H12986

Mon Mar 24 00:00:00 UTC 2025

Add to Cart

Global Acetaminophen API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23A12744

Mon Mar 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »

Global Kidney & Renal Fibrosis Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-10O6067

Global Kidney & Renal Fibrosis Treatment Market Insights, Forecast to 2030

FEATURED COMPANIES

Kidney & Renal Fibrosis Treatment Market Size

Kidney & Renal Fibrosis Treatment Market

Scope of Kidney & Renal Fibrosis Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Kidney & Renal Fibrosis Treatment Market report?

What are the Application segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

What are the Type segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS